2-Hydroxyanthraquinone

CAS No. 605-32-3

2-Hydroxyanthraquinone( —— )

Catalog No. M28101 CAS No. 605-32-3

2-Hydroxyanthraquinone is an acetylated beta-D-glucoside with antitumour and immunosuppressive activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-Hydroxyanthraquinone
  • Note
    Research use only, not for human use.
  • Brief Description
    2-Hydroxyanthraquinone is an acetylated beta-D-glucoside with antitumour and immunosuppressive activity.
  • Description
    2-Hydroxyanthraquinone is an acetylated beta-D-glucoside with antitumour and immunosuppressive activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Antibacterial|Antibiotic
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    605-32-3
  • Formula Weight
    224.215
  • Molecular Formula
    C14H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (446.01 mM)
  • SMILES
    Oc1ccc2C(=O)c3ccccc3C(=O)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Siti Nani Nurbaeti, et al. Sustained-release Microparticle Dry Powders of Chloramphenicol Palmitate or Thiamphenicol Palmitate Prodrugs for Lung Delivery as Aerosols.Eur J Pharm Sci. 2019 Oct 1;138:105028.
molnova catalog
related products
  • Bexmarilimab

    Bexmarilimab (FP-1305) is a highly potent, humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM, promoting immune conversion of tumor-associated macrophage phenotype M2 to M1, and can be used to study cancer.

  • Fomesafen

    Fomesafen is a diphenyl ether herbicide and an inhibitor of efficient and selective protoporphyrinogen IX oxidase (PPO).

  • PF-05231023

    PF-05231023 is a long-acting fibroblast growth factor 21 (FGF21) analog and is an FGF21-receptor agonist. It is also suitable for development as a potential treatment for T2DM. PF-05231023 is a analog of long-acting fibroblast growth factor 21.